ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
10.52
-0.74 (-6.57%)
Nov 20, 2026, 4:00 PM EST - Market closed
ArriVent BioPharma Employees
ArriVent BioPharma had 77 employees as of December 31, 2025. The number of employees increased by 25 or 48.08% compared to the previous year. That makes ArriVent BioPharma the 32,993rd largest employer in the world and 4,272nd in the United States.
Employees
77
Change (1Y)
25
Growth (1Y)
48.08%
Revenue / Employee
$64,935
Profits / Employee
-$2,207,390
Market Cap
544.13M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 77 | 25 | 48.08% |
| Dec 31, 2024 | 52 | 12 | 30.00% |
| Dec 31, 2023 | 40 | - | - |
| Sep 30, 2023 | 42 | - | - |
| Jun 30, 2023 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 485 |
| Wave Life Sciences | 317 |
| Alumis | 253 |
| Sana Biotechnology | 142 |
| Adlai Nortye Group | 109 |
| Cullinan Therapeutics | 109 |
| Orchestra BioMed Holdings | 86 |
| Aclaris Therapeutics | 73 |
AVBP News
- 4 days ago - ArriVent Biopharma price target lowered to $28 from $30 at Guggenheim - TheFly
- 10 days ago - ArriVent Biopharma price target raised to $23 from $20 at Citi - TheFly
- 10 days ago - ArriVent Biopharma price target raised to $24 from $21 at Truist - TheFly
- 11 days ago - ArriVent Biopharma reports Q3 EPS (81c), consensus ($1.06) - TheFly
- 11 days ago - ArriVent BioPharma Reports Third Quarter 2026 Financial Results - GlobeNewsWire
- 11 days ago - ArriVent BioPharma Earnings release: Q3 2026 - Filings
- 11 days ago - ArriVent BioPharma Quarterly report: Q3 2026 - Filings
- 18 days ago - Aarvik Therapeutics Announces Milestone Achievement, Partnership Update, and Presentations on MUTTA™ and AQUALINK™ Platforms at the 17th Annual WADC Conference - Business Wire